vTv Therapeutics Announces Completion of Phase 1b Study Evaluating TTP399 for the Treatment of Type…
vTv Therapeutics Inc. announced the completion of Phase 1b of Simplici-T1, an adaptive Phase 1b/2 study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of…
Read More...
Read More...